1895049-20-3 (Molibresib besylate | GSK 525762C | Epigenetic Reader Domain,Molibresib besylate)

Molibresib besylate;Molibresib (besylate);K04D7I4BCH;GSK525762C;Molibresib besylate (USAN);D11347;2-((4S)-6-(4-Chlorophenyl)-8-methoxy-1-methyl-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepin-4-yl)-N-ethylacetamide monobenzenesulfonate salt;GSK 525762C;I-BET 762 besylate;DA-65590;CS-0094036;AKOS040733306;UNII-K04D7I4BCH;CHEMBL4297217;benzenesulfonic acid;2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide;2-[(4S)-6-(4-Chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide monobenzenesulfonate salt;HY-13032B;G16735;1895049-20-3;GSK-525762C;MOLIBRESIB BESYLATE [USAN];MS-30436;

UQGMFOYDYUZADE-FERBBOLQSA-N

1S/C22H22ClN5O2.C6H6O3S/c1-4-24-20(29)12-18-22-27-26-13(2)28(22)19-10-9-16(30-3)11-17(19)21(25-18)14-5-7-15(23)8-6-14;7-10(8,9)6-4-2-1-3-5-6/h5-11,18H,4,12H2,1-3H3,(H,24,29);1-5H,(H,7,8,9)/t18-;/m0./s1

ClC1C=CC(=CC=1)C1C2C=C(C=CC=2N2C(C)=NN=C2[C@H](CC(NCC)=O)N=1)OC.S(C1C=CC=CC=1)(=O)(=O)O